Fierce Recognizes CareCentrix’s HomeFirstSM Analytics and Hyper-Personalized Care Model as Innovations in Health at Home HARTFORD, Conn., Jan. 10, 2022…
Junshi Biosciences and Coherus plan to evaluate the toripalimab + JS006 combination in clinical trials in multiple tumor typesCombinations of…
WOBURN, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the…
Fueled by strong performance in New Jersey and GeorgiaNASHVILLE, Tenn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Today, Clover Health (Nasdaq:…
Technology is awarded for its advances in mental healthMALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM),…
BrightInsight’s Platform has been selected to Accelerate Continuous Development of one of Sanofi’s Best-In-Class Software as a Medical DeviceSAN JOSE,…
ROSELAND, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,…
BURNABY, British Columbia, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today outlined its…
MARKHAM, Ontario, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today provided…
Overwhelming Majority of Shares Voted by Unaffiliated Stockholderswere in Favor of Scopus' Director Nominees Lasters’ Ownership Position and Annual Meeting…